Could angiotensin-converting enzyme 1 polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?
作者信息
Dević Pavlić Sanja, Nadalin Sergej, Starčević Čizmarević Nada, Buretić-Tomljanović Alena, Radojčić Badovinac Anđelka, Ristić Smiljana
机构信息
Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Croatia.
Department of Biotechnology, University of Rijeka, Croatia.
出版信息
J Renin Angiotensin Aldosterone Syst. 2020 Jul-Sep;21(3):1470320320957157. doi: 10.1177/1470320320957157.
Abstract
摘要
相似文献
1
Could angiotensin-converting enzyme 1 polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?血管紧张素转换酶1基因多态性能否作为不同人群、疾病和/或状况下新冠病毒疾病反应的修饰因子？
J Renin Angiotensin Aldosterone Syst. 2020 Jul-Sep;21(3):1470320320957157. doi: 10.1177/1470320320957157.
2
COVID-19 infections are also affected by human ACE1 D/I polymorphism.新型冠状病毒肺炎感染也受人类血管紧张素转换酶1 D/I多态性的影响。
Clin Chem Lab Med. 2020 Jun 25;58(7):1125-1126. doi: 10.1515/cclm-2020-0425.
3
Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.血液系统恶性肿瘤中的冠状病毒：突破2019冠状病毒病中血管紧张素转换酶2（ACE2）屏障的靶向分子
Pathol Oncol Res. 2020 Oct;26(4):2823-2825. doi: 10.1007/s12253-020-00810-6. Epub 2020 Apr 24.
4
Host Polymorphisms May Impact SARS-CoV-2 Infectivity.宿主多态性可能影响 SARS-CoV-2 感染性。
Trends Genet. 2020 Nov;36(11):813-815. doi: 10.1016/j.tig.2020.08.003. Epub 2020 Aug 10.
5
Genetic predisposition models to COVID-19 infection.新冠病毒感染的遗传易感性模型。
Med Hypotheses. 2020 Sep;142:109818. doi: 10.1016/j.mehy.2020.109818. Epub 2020 May 6.
6
A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.干扰素通过增强血管紧张素转换酶2（ACE2）的表达在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）发病机制中可能发挥的可疑作用。
Signal Transduct Target Ther. 2020 May 21;5(1):71. doi: 10.1038/s41392-020-0185-z.
7
The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.宿主的血管紧张素转换酶多态性可能解释了新冠病毒感染中的流行病学发现。
Clin Chim Acta. 2020 Jun;505:192-193. doi: 10.1016/j.cca.2020.03.031. Epub 2020 Mar 24.
8
[Are there genetic variants that can modify the course of the COVID-19 pandemic?].是否存在能够改变新冠疫情发展进程的基因变异？
Medicina (B Aires). 2020;80 Suppl 3:79-81.
9
Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.血管紧张素转换酶2（ACE2）和跨膜丝氨酸蛋白酶2（TMPRSS2）对新型冠状病毒肺炎（COVID-19）发病率和严重程度的性别介导效应；基因实施的必要性。
Curr Res Transl Med. 2020 Nov;68(4):149-150. doi: 10.1016/j.retram.2020.08.002. Epub 2020 Sep 6.
10
COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.新型冠状病毒肺炎：血管紧张素1-7在血管紧张素转换酶2调节中的关键作用
Ann Acad Med Singap. 2020 Jun;49(6):398-400.
引用本文的文献
1
ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe.血管紧张素转换酶I/D多态性与新型冠状病毒肺炎的流行病学研究结果：欧洲大流行爆发一年后
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.002. Epub 2021 Jun 16.
2
Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.血管紧张素转换酶 1（ACE1）基因 I/D 多态性对 COVID-19 患者严重程度的影响。
Infect Genet Evol. 2021 Jul;91:104801. doi: 10.1016/j.meegid.2021.104801. Epub 2021 Mar 4.
本文引用的文献
1
Gender differences in patients with COVID-19: a narrative review.2019冠状病毒病患者的性别差异：一项叙述性综述
Monaldi Arch Chest Dis. 2020 May 25;90(2). doi: 10.4081/monaldi.2020.1389.
2
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?COVID-19 与个体遗传易感性/接受性：ACE1/ACE2 基因、免疫、炎症和凝血的作用。与男性的单个 X 染色体相比，女性的双 X 染色体是否对 SARS-CoV-2 具有保护作用？
Int J Mol Sci. 2020 May 14;21(10):3474. doi: 10.3390/ijms21103474.
3
ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.血管紧张素转换酶基因插入/缺失多态性与新型冠状病毒肺炎的流行病学研究结果
Clin Chem Lab Med. 2020 Jun 25;58(7):1129-1130. doi: 10.1515/cclm-2020-0605.
4
No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.血管紧张素转换酶（ACE）插入/缺失（Ins/Del）基因多态性与新型冠状病毒肺炎（COVID-19）感染之间无显著相关性。
Clin Chem Lab Med. 2020 Jun 25;58(7):1127-1128. doi: 10.1515/cclm-2020-0577.
5
COVID-19 infections are also affected by human ACE1 D/I polymorphism.新型冠状病毒肺炎感染也受人类血管紧张素转换酶1 D/I多态性的影响。
Clin Chem Lab Med. 2020 Jun 25;58(7):1125-1126. doi: 10.1515/cclm-2020-0425.
6
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report.血管紧张素转换酶插入/缺失基因多态性与多发性硬化症患者对干扰素-β的治疗反应：初步报告
Pharmacogenet Genomics. 2017 Jun;27(6):232-235. doi: 10.1097/FPC.0000000000000283.
7
Angiotensin-converting enzyme insertion/deletion gene polymorphism in lung cancer patients.肺癌患者血管紧张素转换酶插入/缺失基因多态性
Genet Test Mol Biomarkers. 2012 Jul;16(7):722-5. doi: 10.1089/gtmb.2011.0306. Epub 2012 Feb 17.
8
Angiotensin-converting enzyme gene insertion/deletion polymorphism is not associated with schizophrenia in a Croatian population.血管紧张素转换酶基因插入/缺失多态性与克罗地亚人群的精神分裂症无关。
Psychiatr Genet. 2012 Oct;22(5):267-8. doi: 10.1097/YPG.0b013e3283518524.
9
Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans.血管紧张素转换酶缺失等位基因对欧洲人的长寿有益。
Age (Dordr). 2012 Jun;34(3):583-95. doi: 10.1007/s11357-011-9270-0. Epub 2011 May 26.
10
Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis.血管紧张素转换酶I/D基因多态性与多发性硬化症风险
Acta Neurol Scand. 2006 Dec;114(6):374-7. doi: 10.1111/j.1600-0404.2006.00711.x.
Zotero 插件